Abstract
Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders that share overlap** diagnostic criteria ranging in symptom severity. Currently, diagnoses of ASD are based on a triad of observable behaviors including impairments in communication, impairments in socialization, and repetitive behaviors and restricted interests. And, while the prevalence of the disorders comprising the spectrum continues to be on the rise (Rice et al. in Disabil Health J 3:186–201, 2010; Sun and Allison in Res Autism Spect Dis 4:156–167, 2010), the etiology of ASD remains relatively unknown. More concerning for parents of children diagnosed with an ASD is that there is no known cure. As a result, parents are desperate to implement any treatments that have reported effectiveness (Elder et al. in J Autism Dev Disord 36:413–420, 2006), even if reports are anecdotal.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Akins, R. S., Angkustsiri, K., & Hansen, R. L. (2010). Complementary and alternative medicine in autism: An evidence-based approach to negotiating safe and efficacious interventions with families. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 7, 307–319.
AIT Institute. (2010). AIT and autism: Autism spectrum disorders (ASD), auditory processing disorder (ADP), and auditory integration training (Berard AIT). www.aitinsttitute.org/ait_and_auditory_processing_disorder.htm. Accessed 11 Dec 2011.
Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89, 485–491.
American Academy of Pediatrics. (1998). Auditory integration training and facilitated communication for autism. American Academy of Pediatrics: Committee on Children with Disabilities. Pediatrics, 102, 431–433.
American Psychological Association. (2003, Nov 20). Facilitated communication: Sifting the psychological wheat from the chaff. http://www.apa.org/research/action/facilitated.aspx.
American Speech-Language-Hearing Association. (1995). Facilitated communication [Position Statement]. doi: 10.1044/policy.PS1995-00089.
American Speech-Language-Hearing Association. (2004). Auditory integration training [Technical Report]. www.asha.org/docs/html/TR2004-00260.html.
Amminger, G. P., Berger, G. E., Schafer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007). Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study. Biological Psychiatry, 61, 551–553.
Arnold, G. L., Hyman, S. L., Mooney, R. A., & Kirby, R. S. (2003). Plasma amino acids profiles in children with autism: Potential risk of nutritional deficiencies. Journal of Autism and Developmental Disorders, 33, 449–454.
Association for Behavior Analysis International. (1995). Statement on facilitated communication. http://www.abainternational.org/ABA/statements/FC.asp.
Autism National Committee. (2008). Policy and principles regarding facilitated communication [Positive Statement]. http://www.autcom.org/articles/PPFC.pdf.
Ayres, A. J. (1972). Sensory integration and learning disorders. Los Angeles: Western Psychological Services.
Ayres, A. J. (1979). Sensory integration and the child. Los Angeles: Western Psychological Services.
Baranek, G. T., Foster, L. G., & Berkson, G. (1997). Sensory defensiveness in persons with developmental disabilities. Occupational Therapy Journal of Research, 17, 173–185.
Bass, M. M., Duchowny, C. A., & Llabre, M. M. (2009). The effect of therapeutic horseback riding on social functioning in children with autism. Journal of Autism and Developmental Disorders, 39, 1261–1267.
Bebko, J., Perry, A., & Bryson, S. (1996). Multiple method validation study of facilitated communication: II. Individual differences and subgroup results. Journal of Autism and Developmental Disabilities, 26, 19–42.
Bent, S., Bertoglio, K., Ashwood, P., Bostrom, A., & Hendren, R. L. (2011). A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. Journal of Autism and Developmental Disorders, 41, 545–554.
Bent, S., Bertoglio, K., & Hendren, R. (2009). Omega-3 fatty acids for autism spectrum disorder: A systematic review. Journal of Autism and Developmental Disorders, 39, 1145–1154.
Berard, G. (1993). Hearing equals behavior. New Canaan: Keats Publishing.
Berard, G. (2006). Understanding the difference between Berard AIT and the Tomatis method: Guy Berard. http://www.drguyberard.com/tomatis.html.
Bernard, S., Enyati, A., Redwood, L., Roger, H., & Binstock, T. (2001). Autism: A novel form of mercury poisoning. Medical Hypotheses, 56, 462–471.
Biklen, D. (1990). Communication unbound: Autism and praxis. Harvard Educational Review, 60, 291–314.
Biklen, D. (1992). Ty** to talk: Facilitated communication. American Journal of Speech and Language Pathology, 1, 15–17.
Biklen, D. (2005). Autism and the myth of the person alone. New York: NYU Press.
Biklen, D., Morton, M. W., Gold, D., Berrigan, C., & Swaminathan, S. (1992). Faciliatted communication: Implications for individuals with autism. Topics in Language Disorders, 12, 1–28.
Biklen, D., Saha, N., & Kliewer, C. (1995). How teachers confirm the authorship of facilitated communication: A portfolio approach. Journal of the Association for Persons with Severe Handicaps, 20, 45–46.
Blanton, S. J. (2000). Why consultants don’t apply psychological research. Consulting Psychology Journal: Practice and Research, 52, 235–247.
Bomba, C., O’Donnell, L., Markowitz, C., & Holmes, D. (1996). Evaluating the impact of facilitated communication on the communicative competence of fourteen students with autism. Journal of Autism and Developmental Disorders, 26, 43–58.
Braman, B. J., & Brady, M. P. (1995). Facilitated communicaton for children with autism: An examination of face validity. Behavioral Disorders, 26, 43–58.
Bundy, A. C. (2002). The process of planning and implementing intervention. In A. C. Bundy, S. J. Lange, A. G. Fisher, & E. A. Murray (Eds.), Sensory integration: Theory and practice (2nd ed., pp. 212–225). Philadelphia: F. A. Davis.
Burrows, K. E., Adams, C. L., & Spiers, J. (2008). Sentinels of safety: Service dogs ensure safety and enhance freedom and wellbeing for families with autistic children. Quality Health Research, 18, 1642–1649.
Cabay, M. (1994). A controlled evaluation of facilitated communication with four autistic children. Journal of Autism and Developmental Disorders, 24, 517–527.
Cade, R., Privette, M., Fregly, M., Rowland, N., Sun, Z., Zele, V., & Wagemaker, H. (1999). Autism and schizophrenia: Intestinal disorders. Nutritional Neuroscience, 3, 57–72.
Case-Smith, J., & Miller, H. (1999). Occupational therapy with children with pervasive developmental disorders. American Journal of Occupational Therapy, 53, 506–513.
Carey, T., Ratliff-Schaub, K., Funk, J., Weinle, C., Myers, M., & Jenks, J. (2002). Double blind placebo controlled trial of secretin: Effects on abnormal behavior in children with autism. Journal of Autism and Developmental Disorders, 32, 161–1167.
Chen, R. T., & DeStefano, F. (1998). Vaccine adverse events: Causal or coincidental? Lancet, 351, 611–612.
Chez, M. G., Buchanan, C. P., Bradley, T., Bagnan, B. T., Hammer, M. S., McCarthy, K. S., Ovrutskaya, I., Nowinski, C. V., & Cohen, Z. S. (2000). Secretin and autism: A two-part clinical investigation. Journal of Autism and Developmental Disorders, 20, 87–94.
Coniglio, S. J., Lewis, J. D., Lang, C., Burns, T. G., Subbani-Siddique, R., Weintraub, A., & Holden, E. W. (2001). A randomized double-blind, placebo controlled trial of a single dose of intravenous secretin as treatment for children with autism. The Journal of Pediatrics, 138, 649–655.
Coplan, J., Sounders, M. C., Mulberg, A. E., Belchie, J. K., Wray, J., Jawad, A. F., & Levy, S. E. (2003). Children with autistic spectrum disorders. II: Parents are unable to distinguish secretin from placebo under double-blind conditions. Archives of the Disease of Childhood, 88, 737–739.
Corbett, B., Khan, K., Czapansky-Beilman, D., Brady, N., Dropik, P., Goldman, D. Z., & Ziegler, R. (2001). A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism. Clinical Pediatrics, 40, 327–331.
Crews, D. W., Sanders, E. C., Hensley, L. G., Johnson, Y. M., Bonaventura, S., Rhodes, R. D., et al. (1995). An evaluation of facilitated communication in a group of nonverbal individuals with mental retardation. Journal of Autism and Developmental Disorders, 25, 205–213.
Crossley, R. (1992). Getting the words out II: Case studies in facilitated communication training. Topics in Language Disorders, 12, 46–59.
Crossley, R. (1994). Facilitated communication training. New York: Teachers College Press.
Crossley, R., & McDonald, A. (1980). Annie’s coming out. New York: Penguin Books.
Dales, L., Hammer, S. J., & Smith, N. J. (2001). Time trends in autism and in MMR immunization coverage in California. Journal of the American Medical Association, 285, 1183–1185.
Daems, J. (1994). Reviews of research in sensory integration. Torrance: Sensory Integration International.
Dawson, G., & Watling, R. (2000). Interventions to facilitate auditory, visual, and motor integration in autism: A review of the evidence. Journal of Autism and Developmental Disorders, 30, 415–421.
Devlin, S., Healy, O., Leader, G., & Hughes, B. M. (2010). Comparison of behavioral intervention and sensory-integration therapy in the treatment of challenging behavior. Journal of Autism and Developmental Disorders, 41, 1303–1320.
Devlin, S., Leader, G., & Healy, O. (2009). Comparison of behavioral intervention and sensory-integration therapy in the treatment of self-injurious behavior. Research in Autism Spectrum Disorders, 3, 223–231.
Dietrich, K. N., Ware, J. H., Salganik, M., Radcliffe, J., Rogan, W. J., Rhoads, G. G., Fay, M. E., Davoli, C. T., Denckla, M. B., Bornschein, R. L., Schwarz, D., Dockery, D. W., Adubato, S., & Jones, R. L. (2004). Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. Pediatrics, 114, 19–26.
Eberlin, M., McConnachie, G., Ibel, S., & Volpe, L. (1993). Facilitated communication: A failure to replication the phenomenon. Journal of Autism and Developmental Disorders, 23, 507–530.
Edelson, S. M., Arin, D., Bauman, M., Lukas, S. E., Rudy, J. H., Sholar, M., et al. (1999). Auditory integration training: A double-blind study of behavioral and electrophysiological effects in people with autism. Focus on Autism and Other Developmental Disabilities, 14, 73–81.
Elder, J. H., Shankar, M., Shuster, J., Theriaque, D., Burns, S., & Sherrill, L. (2006). The gluten-free, casein-free diet in autism: Results of a preliminary double blind clinical trial. Journal of Autism and Developmental Disorders, 36, 413–420.
Eritsland, J. (2000). Safety considerations of polyunsaturated fatty acids. American Journal of Clinical Nutrition, 71(Suppl. 1), 197s–201s.
Findling, R. L., Maxwel, K., Scotese-Wojtila, L., Husang, J., Yamashita, T., & Wiznitzer, M. (1997). High-dose pyridoxine and magnesium administration in children with autistic disorder: An absence of salutary effects in a double-blind placebo-controlled study. Journal of Autism and Developmental Disabilities, 27, 467–478.
Gabriels, R. L., Agnew, J. A., Holt, K. D., Shoffner, A., Zhaoxing, P., Ruzzano, S., Clayton, G. H., & Mesibov, G. (2012). Pilot study measuring the effects of therapeutic horseback riding on school-age children and adolescents with autism spectrum disorders. Research in Autism Spectrum Disorders, 6, 578–588. doi: 10.1016/j.rasd.2011.09.007.
Gillberg, C., Ehlers, S., Schaumann, H., Jakobsson, G., Dahlgren, S. O., Lindblom, R., et al. (1990). Autism under age 3 years: A clinical study of 28 cases referred for autistic symtpoms in infancy. Journal of Child Psychology and Psychiatry, 31, 921–934.
Goldstein, H. (2000). Commentary: Interventions to facilitate auditory, visual, and motor integration: “Show me the data.” Journal of Autism and Developmental Disorders, 30, 423–425.
Grandin, T., Fine, A. H., & Bowers, C. M. (2010). The use of therapy animals with individuals with autism spectrum disorder. In A. H. Fine (Ed.), Handbook on animal-assisted therapy. Oxford: Elsevier.
Granpeesheh, D., Tarbox, J., Dixon, D. R., Wilke, A. E., Allen, M. S., & Bradstreet, J. J. (2010). Randomized trial of hyperbaric oxygen therapy for children with autism. Reseach in Autism Spectrum Disorders, 4, 268–275.
Green, G. (1996). Evaluating claims about treatment for autism. In C. Maurice, G. Green, & S. Luce (Eds.), Behavioral intervention for young children with autism: A manual for parents and professionals (pp. 15–28). Austin: PRO–ED.
Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reilly, M., & Sigafood, J. (2006). Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities, 27, 70–84.
Halsey, N. A., & Hyman, S. L. (2001). Measles-mumps-rubella vaccine and autistic spectrum disorder: Report from the New Challenges in Childhood Immunization Conference convened in Oak Brook, Illinois June 12–13, 2000. Pediatrics, 107, 84.
Hayward, D., Eikeseth, S., Gale, C., & Morgan, S. (2009). Assessing progress during treatment for young children with autism receiving behavioural interventions. Autism: The International Journal of Research and Practice, 13, 613–633.
Hediger, M. L., England, L. J., Molloy, C. A., Yu, K. F., Manning-Courtney, P., & Mills, J. L. (2008). Reduced bone cortical thickness in boys with autism or autism spectrum disorder. Journal of Autism and Developmental Disorders, 38, 848–856.
Hodgetts, S., & Hodgetts, W. (2007). Somatosensory stimulation interventions for children with autism: Literature review and clinical considerations. Canadian Journal of Occupational Therapy, 74, 393–400.
Honomichl, R. D., Goodlin-Jones, B. L., Burnham, M. M., Hansen, R. L., & Anders, T. R. (2002). Secretin and sleep in children with autism. Child Psychiatry and Human Development, 33, 107–123.
Horvath, K., Stefanatos, G., Sokolski, K. N., Wachtel, R., Nabors, L., & Tildon, J. T. (1998). Improved social and language skills after secretin administration in patients with autistic spectrum disorders. Journal of the Association for Academic Minority Physicians, 9, 9–15.
Ip, P., Wong, V., Ho, M., Lee, J., & Wong, W. (2004). Mercury exposure in children with autistic spectrum disorder: Case-control study. Journal of Child Neurology, 19, 431–434.
Jacobson, J. W., Foxx, R. M., & Mulick, J. A. (2005). Facilitated communication: The ultimate fad treatment. In J. W. Jacobson, R. M. Foxx, & J. A. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion, and science in professional practice (pp. 363–383). Mahwah: Lawrence Erlbaum.
Kasari, C. (2002). Assessing change in early intervention programs for children with autism. Journal of Autism and Developmental Disorders, 32, 447–461.
Kern, J. K., Van Miller, S., Evans, P. A., & Trivedi, M. H. (2002). Efficacy of porcine secretin in children with autism and pervasive developmental disorder. Journal of Autism and Developmental Disorders, 32, 153–160.
Klewe, L. (1993). An empirical evaluation of spelling boards as a means of communication for the multihandicapped. Journal of Autism and Developmental Disorders, 23, 559–566.
Koves, K., Kausz, M., Reser, D., Illyés, G., Takács, J., Heinzlmann, A., Gyenge, E., & Horváth, K. (2004). Secretin and autism: A basic morphological study about the distribution of secretin in the nervous system. Regulatory Peptides, 123, 209–216.
Kuddo, T., & Nelson, K. B. (2003). How common are gastrointestinal disorders in children with autism? Current Opinion in Pediatrics, 15, 339–343.
Krug, D. A., Arick, J., & Almond, P. (1993). Autism screening instrument for educational planning. Austin: Pro-Ed.
Kuntz, A., Clement, H. W., Lehnert, W., van Calker, D., Hennighausen, K., Gerlach, M., & Schulz, E. (2004). Effects of secretin on extracellular amino acid concentrations in rat hippocampus. Journal of Neural Transmission, 111, 931–939.
Kuriyama, S., Kamiyama, M., Watanabe, M., Tamahashi, S., Muraguchi, I., Watanabe, T., Hozawa, A., Ohkubo, T., Nishino, Y., Tsubono, Y., Tsuji, I., & Hisamichi, S. (2002). Pyridoxine treatment in a subgroup of children with pervasive developmental disorders. Developmental Medicine & Child Neurology, 44, 283–286.
Leach, R. M., Rees, P. J., & Wilmshurst, P. (1998). Hyperbaric oxygen therapy. British Medical Journal, 317, 1140–1143.
Leong, H. M., & Carter, M. (2008). Research on the efficacy of sensory integration therapy: Past, present, and future. Australasian Journal of Special Education, 32, 83–99.
Levy, S. E., & Hyman, S. L. (2005). Novel treatments for autistic spectrum disorders. Mental Retardation and Developmental Disabilities Research Reviews, 11, 131–142.
Levy, S. E., Mandell, D. S., Merhar, S., Ittenbach, R. F., & Pinto-Martin, J. (2003). Use of complementary and alternative medicine among children recently diagnosed with autism spectrum disorder. Journal of Developmental and Behavioral Pediatrics, 24, 418–423.
Levy, S. E., Sounders, M. C., Wray, J., Jawad, A. F., Gallagher, P. R., Coplan, J., Belchic, J. K., Gerdes, M., Mitchell, R., & Mulberg, A. E. (2003). Children with autistic spectrum disorders. I: Comparison of placebo and single dose of human secretin. Archives of Disease in Childhood, 88, 731–736.
Marino, L., & Lilienfeld, S. O. (2007). Dolphin-assisted therapy: More flawed data and more flawed conclusions. Antrozoös, 20, 239–249.
Martin, F., & Farnum, J. (2002). Animal assisted therapy for children with pervasive developmental disorders. Western Journal of Nursing Research, 24, 657–670.
Martin, E. R., Menold, M. M., Wolpert, C. M., Bass, M. P., Donnelly, S. L., Ravan, S. A., Zimmerman, A., Gilbert, J. R., Vance, J. M., Maddox, L. O., Wright, H. H., Abramson, R. K., DeLong, G. R., Cuccaro, M. L., & Pericak-Vance, M. A. (2000). Analysis of linkage disequilibrium in aminobutyric acid receptor subunit genes in autistic disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 96, 43–48.
Mason, S. A., & Iwata, B. A. (1990). Artifactual effects of sensory-integrative therapy on self-injurious behavior. Journal of Applied Behavior Analysis, 23, 361–370.
Matson, J. L., & Minshawi, N. F. (2006). Early intervention for autism spectrum disorders: A critical analysis. Oxford: Elsevier Science Inc.
McDonough, M., Carson, S., Ash, J., Russman, B. S., Krages, K. P., & Helfand, M. (2003). Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke. Evidence report/technology assessment No. 85. AHRQ Publication No. 04-E003. Rockfield: Agency for Healthcare Research and Quality.
Meguid, N. A., Atta, H. M., Gouda, A. S., & Khalil, R. O. (2008). Role of polyunsaturated fatty acids in the management of Egyptian children with autism. Clinical Biochemistry, 41, 1044–1048.
Metz, B., Mulick, J., & Butter, E. M. (2004). Autism: A late twentieth century fad magnet. In J. Jacobson, J. A. Mulick, & R. M. Foxx (Eds.), Fads, controversies, and politically correct treatment in developmental disabilities. Hillsdale: Lawrence Erlbaum Associates.
Miller, L. J. (2003). Empirical evidence related to therapies for sensor processing impairments. Communique, 31, 34–37.
Mitka, M. (2008). Chelation therapy trials halted. The Journal of the American Medical Association, 300, 2236.
Molloy, C. A., Manning-Courtney, P., Swayne, S., Bean, J., Brown, J. M., Murray, D. S., Kinsman, A. M., Brasington, M., & Ulrich, D. D. (2002). Lack of benefit of intravenous synthetic human secretin in the treatment of autism. Journal of Autism and Developmental Disorders, 32, 545–551.
Montee, B. B., Miltenberger, R. G., Wittrock, D., Watkins, N., Rheinberger, A., & Stackhaus, J. (1995). An experimental analysis of facilitated communication. Journal of Applied Behavior Analysis, 28, 189–200.
Moore, S., Donovan, B., Hudson, A., Dykstra, J., & Lawrence, J. (1993). Evaluation of eight case studies of facilitated communication. Journal of Autism and Developmental Disorders, 23, 531–539.
Mostert, M. P. (2001). Facilitated communication since 1995: A review of published studies. Journal of Autism and Developmental Disorders, 31, 287–313.
Mudford, O. C., & Cullen, C. (2005). Auditory integration training: A critical review. In J. W. Jacobson, R. M. Foxx, & J. A. Mulick (Eds.), Controversial therapies for developmental disabiliteis: Fad, fashion, and science in professional practice (pp. 352–362). Mahwah: Lawrence Erlbaum Associates.
Mulloy, A., Lang, R., O’Reilly, M., Sigafoos, J., Lancioni, G., & Rispoli, M. (2010). Gluten-free and casein-free diets in the treatment of autism spectrum disorders: A systematic review. Research in Autism Spectrum Disorders, 4, 328–339.
Myles, B. S., Simpson, R. L., & Smith, S. M. (1996). Collateral behavioral and social effects of using facilitated communication with individuals with autism. Focus on Autism and Other Developmental Disabilities, 11, 163–169.
Nathanson, D. E. (1998). Long-term effectiveness of dolphin-assisted therapy for children with severe disabilities. Antrozoös, 11, 22–32.
Nathanson, D. E., de Castro, D., Friend, H., & McMahon, M. (1997). Effectiveness of short-term dolphin-assisted therapy for children with severe disabilities. Antrozoös, 10, 90–100.
National Board for Certification in Occupational Therapy. (2004). A practice analysis for entry-level occupational therapist registered and certified occupational therapy assistant practice. Occupational Therapy Journal of Research, 24(Suppl. 1), 1–31.
National Institute of Child Health & Human Development. (1998). The use of secretin to treat autism. http://www.nichd.nih.gov/news/releases/secretin.cfm. Accessed 14 Nov 2011.
Nelson, K. B., & Bauman, M. L. (2003). Thimerosal and autism? Pediatrics, 111, 674–679.
Nelson, K. B., Grether, J. K., Croen, L. A., Dambrosia, J. M., Dickens, B. F., Jelliffe, L. L., Hansen, R. L., & Phillips, T. M. (2001). Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Annals of Neurology, 49, 597–606.
Newson, C., & Hoanitz, C. A. (2005). The nature and value of empirically validated interventions. In J. W. Jacobson, R. M. Foxx, & J. A. Mulick (Eds.), Controversial therapies for developmental disabiliteis: Fad, fashion, and science in professional practice (pp. 31–57). Mahway: Lawrence Erlbaum Associates.
Nye, C., & Brice, A. (2005). Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database of Systematic Reviews, 4. doi:10.1002/14651858.CD003497.pub2.
Panksepp, J. (1979). A neurochemical theory of autism. Trends in Neurosciences, 2, 176–177.
Parham, L. D., Cohn. E. S., Spitzer, S., Koomar, J. A., Miller, L., Burke, J. P., et al. (2007). Fidelity in sensory integration intervention research. American Journal of Occupational Therapy, 61, 216–227.
Pavone, L., & Ruggieri, M. (2005). The problem of alternative therapies in autism. In M. Coleman (Ed.), The neurology of autism. Oxford: Oxford University Press.
Peltola, H., Patja, A., Leinikki, P., Valle, M., Davidkin, I., & Paunio, M. (1998). No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet, 351, 1327–1328.
Pfeiffer, S. I., Norton, J., Nelson, L., & Shott, S. (1995). Efficacy of vitamin B6 and magnesium in the treatment of autism: A methodology review and summary of outcomes. Journal of Autism and Developmental Disorders, 25, 481–493.
Ratliff-Schaub, K., Carey, T., Reeves, G. D., & Rogers, M. A. M. (2005). Randomized controlled trial of transdermal secretin on behavior of children with autism. Autism: The International Journal of Research and Practice, 9, 256–265.
Regal, R. A., Rooney, J. R., & Wandas, T. (1994). Facilitated communication: An experimental evaluation. Journal of Autism and Developmental Disorders, 24, 345–355.
Reichow, B., Volkmar, F. R., & Chicchetti, D. V. (2008). Development of the evaluative method for evaluating and determining evidence-based practices in autism. Journal of Autism and Developmental Disorders, 38, 1311–1319.
Rice, C., Nicholas, J., Baio, J., Pettygrove, S., Lee, L.-C., Van Naarden Braun, K., Doernberg, N., Cunniff, C., Newschaffer, C., Meaney, F. J., Charles, J., Washington, A., King, L., Kolotos, M., Mancilla, K., Mervis, C. A., Carpenter, L., & Yeargin-Allsopp, M. (2010). Changes in autism spectrum disorder prevalence in 4 areas of the United States. Disability and Health Journal, 3, 186–201.
Richardson, A. J. (2004). Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders. Lipids, 39, 1215–1222.
Rimland, B. (1964). Infantile autism: The syndrome and its implications for neural theory of behavior. New York: Appleton Century Crofts.
Rimland, B., & Edelson, S. M. (1994). The effects of auditory integration training on autism. American Journal of Speech-Language Pathology, 3, 16–24.
Rimland, B., & Edelson, S. M. (1995). Brief report: A pilot study of auditory integration training in autism. Journal of Autism and Developmental Disorders, 25, 61–70.
Roberts, W., Weaver, L., Brian, J., Bryson, S., Emelianova, S., Griffiths, A. M., MacKinnon, B., Yim, C., Wolpin, J., & Koren, G. (2001). Repeated doses of porcine secretin in the treatment of autism: A randomized, placebo controlled trial. Pediatrics, 107, e71.
Rogan, W. J., Dietrich, K. N., Ware, J. H., Dockery, D. W., Salganik, M., Radcliffe, J., Jones, R. L., Ragan, N. B., Chisolm, J. J., Jr., & Rhoads, G. G. (2001). The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. The New England Journal of Medicine, 344, 1421–1426.
Romanczyk, R. G., Arnstein, L., Sorrya, L., & Gillis, J. (2003). The myriad of controversial treatments for autism: A critical evaluation of efficacy. In S. O. Lilienfeld, S. J. Lynn, & J. M. Lohr (Eds.), Science and pseudoscience in clinical psychology (pp. 363–395). New York: Guilford Press.
Rossignol, D. A. (2007). Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. Medical Hypotheses, 68, 1208–1227.
Rossignol, D. A., & Rossignol, L. W. (2006). Hyperbaric oxygen therapy may improve symptoms in autistic children. Medical Hypotheses, 67, 216–228.
Rossignol, D. A., Rossignol, L. W., James, S. W., Melnyk, S., & Mumper, E. (2007). The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: An open-label pilot study. BMC Pediatrics, 7, 21. doi: 10.1186/1471.2431.7.36.
Rossignol, D. A., Rossignol, L. W., Smith, S., Schneider, C., Logerquist, S., Usman, A., Neubrander, J., Madren, E. M., Hintz, G., Grushkin, B., & Mumper, E. A. (2009). Hyperbaric treatment for children with autism: A multicenter randomized, double-blind, controlled trial. BMC Pediatrics, 9, 36. doi: 10.1186/1471/2431/9/21.
S.223. (2009). An act to improve augmentatitve and alternative communication opportunities for children with disabilities. The Commonwealth of Massachusetts. http://www.mass.gov.legis/bills/senate/186/st00pdf/st00223.pdf.
Sandler, A. D., & Bodfish, J. W. (2000). Placebo effects in autism: Lessons from secretin. Journal of Developmental and Behavioral Pediatrics, 21, 347–350.
Sandler, A. D., Sutton, K. A., SeWeese, J., Girardi, M. A., Sheppard, V., & Bodfish, J. W. (1999). Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive and developmental disorder. The New England Journal of Medicine, 341, 1801–1806.
Schaaf, R. C., & Miller, L. J. (2005). Occupational therapy using a sensory integrative approach for children with developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews, 11, 143–148.
Schaumburg, J., Kaplan, J., Windebank, A., Vick, N., Rasmus, S., Pleasure, D., & Brown, M. J. (1983). Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. New England Journal of Medicine, 309, 445–448.
Shane, H., & Kearns, K. (1994). An estimation of the role of the facilitator in “Facilitated Communication.” American Journal of Speech-Language Pathology, 3, 48–54.
Shattock, P., & Whiteley, P. (2002). Biochemical aspects in autism spectrum disorders: Updating the opiod-excess theory and presenting new opportunities for biomedical intervention. Expert Opinion on Therapeutic Targets, 6, 175–183.
Simpson, R. L., & Myles, B. S. (1995). Effectiveness of facilitated communication with children and youth with autism. Journal of Autism and Developmental Disorders, 23, 175–183.
Sinha, Y., Silove, N., Wheeler, D., & Williams, K. (2006). Auditory integration training and other sound therapies for autism spectrum disorders: A systematic review. Archives of Disease in Childhood, 91, 1018–1022.
Smith, M. D., Haas, P. J., & Belcher, R. G. (1994). Facilitated communication: The effects of facilitated knowledge and level of assistance on output. Journal of Autism and Developmental Disorders, 24, 357–367.
Smith, T., Mruzek, D. W., & Mozingo, D. (2005). Sensory integration therapy. In J. W. Jacobson, R. M. Foxx, & J. A. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion, and science in professional practice. Mahway: Lawrence Erlbaum Associates.
Spitzer, S., Roley, S. S., Clark, F., & Parham, D. (1996). Sensory integration: Current trends in the United States. Scandinavian Journal of Occupational Therapy, 3, 123–138.
Sponheim, E., Oftedal, G., & Helverschou, S. B. (2002). Multiple doses of secretin in the treatment of autism: A controlled study. Acta Pediatrica, 91, 540–545.
Stangle, D. E., Smith, D. R., Beaudin, S. A., Strawderman, M. S., Levitsky, D. A., & Strupp, B. J. (2007). Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure. Environmental Health Perspectives, 115, 201–209.
Stock-Kranowitz, C. (1998). The out of synch child: Recognizing and co** with sensory integration dysfunction. New York: Perigree.
Stratton, K., Gable, A., Shetty, P., & McCormick, M. (2001). Immunization safety review: Measles-mumps-rubella vaccine and autism. Washington, DC: National Academy Press.
Sturmey, P., & Fitzer, A. (2007). Autism spectrum disorders: Applied behavior analysis, evidence, and practice. Austin: PRO-ED, Inc.
Sun, X., & Allison, C. (2010). A review of the prevalence of autism spectrum disorders in Asia. Research in Autism Spectrum Disorders, 4, 156–167.
Szempruch, J., & Jacaobson, J. (1993). Evaluating facilitated communication skills of people with developmental disabilities. Research in Developmental Disabilities, 14, 253–264.
The Association for Persons with Severe Handicaps. (2000, Dec). TASH resolution on augmentative and alternative communication methods and the right to communicate. http://www.tash.org/advocacy-issues/human-rights/.
Task Force on Promotion and Dissemination of Psychological Procedures. (1995). Training in and dissemination of empirically validated psychological treatments: Report and recommendations. The Clinical Psychologist, 48, 3–23.
Taylor, B., Miller, E., Farrington, C. P., Petropoulos, M., Favot-Mayaud, I., Li, J., & Waight, P. A. (1999). Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association. Lancet, 353, 2026–2029.
Tolbert, L., Haigler, T., Waits, M. M., & Dennis, T. (1993). Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium. Journal of Autism and Developmental Disabilities, 23, 193–199.
Tuzikow, J. E., & Holburn, S. (2011). Identifying fad therapies for autism spectrum disorders and promoting effective treatment. In J. L. Matson & P. Sturmey (Eds.), International handbook of autism and pervasive developmental disorders. New York: Springer.
Vargas, S., & Camilli, G. (1999). A meta-analysis of research on sensory integration treatment. American Journal of Occupational Therapy, 53, 189–198.
Watling, R., Deitz, J., Kanny, E. M., & McLaughlin, J. F. (1999). Current practice of occupational therapy for children with autism. American Journal of Occupational Therapy, 53, 498–505.
Wecker, L., Miller, S. B., Cochran, S. R., Duggar, D. L., & Johnson, W. D. (1985). Trace element concentrations in hair from autistic children. Journal of Mental Deficiency Research, 29, 15–22.
Welch, M. G., Keune, J. D., Welch-Horan, T. B., Anwar, N., Anwar, M., & Ruggiero, A. (2003). Secretin activates visceral brain regions in the rat including areas abnormal in autism. Cellular and Molecular Neurobiology, 23, 817–837.
Wheeler, D., Jacobson, J., Paglieri, R., & Schwartz. A. (1993). An experimental assessment of facilitated communication. Mental Retardation, 31, 49–60.
Williams, P. G., Hersh, J. H., Allard, A., & Sears, L. L. (2008). A controlled study of mercury levels in hair samples of children with autism compared to their typically develo** siblings. Research in Autism Spectrum Disorders, 2, 170–175.
Williamson, C. (2008). Dolphin assisted therapy” Can swimming with dolphins be a suitable treatment. Developmental Medicine & Child Neurology, 50, 477.
Yung, W. H., Leung, P. S., Ng, S. S. M., Zhang, J., Chan, S. C. Y., & Chow, B. K. C. (2001). Secretin facilitates GABA transmission in the cerebellum. Journal of Neuroscience, 21, 7063–7068.
Zane, T., Davis, C., & Rosswurm, M. (2009). Research: The cost of fad treatments in autism. Journal of Early and Intensive Behavior Intervention, 5, 44–56.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Worley, J., Fodstad, J., Neal, D. (2014). Controversial Treatments for Autism Spectrum Disorders. In: Tarbox, J., Dixon, D., Sturmey, P., Matson, J. (eds) Handbook of Early Intervention for Autism Spectrum Disorders. Autism and Child Psychopathology Series. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0401-3_23
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0401-3_23
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0400-6
Online ISBN: 978-1-4939-0401-3
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)